妊娠期丙型肝炎病毒筛查实践调查
该质量改进项目通过电子问卷评估高流行区三级医疗中心产科医生对妊娠期丙型肝炎病毒(HCV)筛查的实践。38名受访者中,仅41.9%能正确识别全部推荐筛查风险因素;77.8%依据风险因素筛查,13.9%筛查所有孕妇。结论认为基于风险的筛查可能因提供者识别风险因素不一致而效果欠佳。
要点
- 仅41.9%受访者能正确识别全部推荐HCV筛查风险因素。
- 77.8%受访者基于风险因素筛查,仅13.9%筛查所有孕妇。
- 提供者识别风险因素不一致,基于风险的筛查可能效果欠佳。
核心结论
- 基于风险的HCV筛查可能因提供者识别风险因素不一致而效果欠佳,普遍筛查或可减少妊娠期未诊断的HCV感染。
研究设计与样本
- 电子10问题问卷调查,经Tufts Medical Center IRB审核豁免,邮件发送给提供产科照护的住院医师和主治医师。
- 共41名受访者中38名(92.6%)提供回复,其中主治医师17名(44.7%)、专科培训医师4名(10.5%)、住院医师17名(44.7%)。
主要发现
- 16/37(43.2%)受访者认为所有孕妇均应筛查HCV,20/37(54.1%)认为仅风险因素孕妇应筛查。
- 仅13/31(41.9%)受访者能正确识别全部推荐筛查风险因素。
- 5/36(13.9%)受访者筛查所有孕妇,28/36(77.8%)基于风险因素筛查。
关键数值与推荐
- 美国感染病学会和美国肝病研究学会推荐妊娠期普遍HCV筛查,而美国妇产科医师学会和母胎医学会推荐基于风险的筛查。
- 美国孕妇HCV感染从2009年到2014年增加89%,母亲传播给婴儿的风险约为4%至7%。
临床怎么用
- 产科医生应提高对HCV筛查风险因素的识别准确性,并考虑普遍筛查以减少妊娠期未诊断感染。
局限性
- 调查仅限单一三级医疗中心,样本量小(38名受访者),结果可能不能推广至其他机构。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: In 2016, the incidence of acute hepatitis C virus infection was 1.0 per 100,000 persons in the United States and 6.2 per 100,000 persons in Massachusetts. Hepatitis C virus infection among pregnant women in the United States increased by 89% from 2009 to 2014. The risk of a mother with hepatitis C virus infection transmitting the infection to her infant is approximately 4% to 7%. The Infectious Disease Society of America and the American Association for the Study of Liver Diseases recommend universal hepatitis C virus screening in pregnancy, whereas the American College of Obstetricians and Gynecologists and the Society for Maternal-Fetal Medicine recommend risk-based screening. OBJECTIVE: The objective of this quality improvement project was to assess the hepatitis C virus screening practices of obstetricians and gynecologists at a tertiary care center located in a high endemic area for hepatitis C virus infection. STUDY DESIGN: An electronic 10-question survey was reviewed by the Tufts Medical Center Institutional Review Board and found to be exempt from institutional review board approval. The survey was emailed to resident and attending physicians who provide obstetrical care. RESULTS: Of a total of 41 respondents, 38 (92.6%) provided responses; of these 38 respondents, 17 (44.7%) were attending physicians, 4 (10.5%) were fellows, and 17 (44.7%) were resident physicians. In addition, 16 of 37 (43.2%) respondents answered that all pregnant women should be screened for hepatitis C virus, whereas 20 of 37 (54.1%) respondents thought only pregnant women with risk factors for hepatitis C virus infection should be screened. Furthermore, only 13 of 31 (41.9%) respondents correctly identified all of the recommended risk factors that should prompt screening for hepatitis C virus. When asked about their clinical practice, 5 of 36 (13.9%) respondents indicated that they screen all pregnant patients, whereas 28 of 36 (77.8%) respondents indicated that they screen patients based on their risk factors for hepatitis C virus infection. CONCLUSION: Our survey showed that risk-based screening for hepatitis C virus may be less effective than universal screening because healthcare providers are not consistent in identifying risk factors for hepatitis C virus infection. Universal screening could decrease the amount of hepatitis C virus infections that go undiagnosed in pregnancy.
引用
- Koniares KG, Fadlallah H, Kolettis DS, et al. Hepatitis C virus screening in pregnancy. Am J Obstet Gynecol MFM. 2020. PMID: 33345869. doi:10.1016/j.ajogmf.2020.100123
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。